Clinical Trial Update: CANBESURE STUDY (Cancer, Bemiparin and Surgery Evaluation) [Phase 3]

View source ↗

Summary

Phase 3 CANBESURE study evaluating bemiparin in cancer patients undergoing surgery for venous thromboembolism has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Venous Thromboembolism

Drugs mentioned

• Bemiparin (bemiparin)

Snippet

Sponsor: Rovi Pharmaceuticals Laboratories | Conditions: Cancer, Venous Thromboembolism | Phase 3 | Status: COMPLETED